(firstQuint)Familiarization and Safety Study of PB127 Ultrasound Contrast Agent.

 The primary objectives of this clinical trial are: 1.

 To train potential Phase 3 investigational sites in the preparation and andministration of PB127 2.

 To train potential Phase 3 investigational sites in the acquisition of adequate images 3.

 To collect additional safety information regarding intravenous administration of PB127 4.

 To obtain a larger sample of images obtained with the Acuson Sequoia ultrasound system.

.

 Familiarization and Safety Study of PB127 Ultrasound Contrast Agent@highlight

The purpose of this study is to evaluate preparation and administration of PB127, echocardiographic images obtained during PB127 administration, and evaluate the safety of PB127.

